Article
Stimulation of differentiation in sodium-dependent vitamin C transporter 2 overexpressing MC3T3-E1 osteoblasts.
Department of Toxicology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
Biochemical and Biophysical Research Communications (impact factor:
2.48).
06/2004;
317(4):1159-64.
DOI:10.1016/j.bbrc.2004.03.158
pp.1159-64
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: The SLC23 family of ascorbate transporters: ensuring that you get and keep your daily dose of vitamin C.
[show abstract] [hide abstract]
ABSTRACT: The ascorbate transporters SVCT1 and SVCT2 are crucial for maintaining intracellular ascorbate concentrations in most cell types. Although the two transporter isoforms are highly homologous, they have different physiologic functions. The SVCT1 is located primarily in epithelial cells and has its greatest effect in reabsorbing ascorbate in the renal tubules. The SVCT2 is located in most non-epithelial tissues, with the highest expression in brain and neuroendocrine tissues. These transporters are hydrophobic membrane proteins that have a high affinity and are highly selective for ascorbate. Their ability to concentrate ascorbate inside cells is driven by the sodium gradient across the plasma membrane as generated by Na+/K+ ATPase. They can concentrate ascorbate 20 to 60-fold over plasma ascorbate concentrations. Ascorbate transport on these proteins is regulated at the transcriptional, translational and post-translational levels. Available studies show that transporter function is acutely regulated by protein kinases A and C, whereas transporter expression is increased by low intracellular ascorbate and associated oxidative stress. The knockout of the SVCT2 in mice is lethal on day 1 of life, and almost half of SVCT1 knockout mice do not survive to weaning. These findings confirm the importance both of cellular ascorbate and of the two transport proteins as key to maintaining intracellular ascorbate. LINKED ARTICLES This article is part of a themed section on Transporters. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2011.164.issue-7.British Journal of Pharmacology 03/2011; 164(7):1793-801. · 4.41 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
AA
AA uptake
Alkaline phosphatase activity
ascorbic acid
control cells
increase calcium deposition
MC3T3-E1 osteoblasts
mineralization
OPN mRNA
osteoblast differentiation
PO4(3-)-stimulated osteopontin
previous studies
Sodium-dependent vitamin C transporter
SVCT2 expression
SVCT2 overexpression
SVCT2 stimulates osteoblast differentiation
SVCT2-introduced cells overexpressed SVCT2 mRNA
SVCT2-overexpressing cells
up-regulation effect
Zn-induced osteoblast differentiation